Corvus begins phase 1 Covid-19 clinical trial with novel immunotherapy

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 8, 2020 at 10:52 AM.

  1. #1 cafead, Jul 8, 2020 at 10:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Clinical-stage biopharmaceutical firm Corvus Pharmaceuticals has commenced the phase 1 clinical study of novel Immunotherapy for patients with Covid-19 disease.

    article source
     
    Quote

Reply to Thread